Genital Herpes
Authors:
- 1 February 1994
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 47 (2) , 297-304
Abstract
The pharmacological therapy for genital herpes simplex virus (HSV) infection remains dominated by aciclovir, although a number of related compounds are currently under investigation. Recommended treatment for initial genital HSV infection is oral aciclovir 200mg 5 times daily for 5 days, with intravenous therapy reserved for complicated episodes. Although topical aciclovir may be of benefit, no improvement in the systemic symptoms is provided by this formulation. No preparation prevents the onset of recurrent episodes. The management of recurrent episodes is more controversial, with studies of episodic treatment with both topical and oral aciclovir yielding mixed and at times conflicting results. Episodic treatment with oral aciclovir initiated early by the patient appears to have the most favourable results, and if initiated at the onset of prodromal symptoms may abort the episode in some patients. In patients with frequent recurrences, suppressive therapy with oral aciclovir should be considered. A starting dose of 200mg 4 times daily appears to be the most effective, although 400mg twice daily may suffice. The total daily dose should be reduced as far as possible, and treatment should be interrupted on a yearly basis to determine the need for continuing suppression. The management and pharmacological therapy of genital HSV in pregnancy remains controversial and studies of oral aciclovir in late pregnancy are currently under way. Genital HSV infection may be particularly severe in the immunocompromised host and suppressive oral aciclovir should be initiated promptly. HSV resistance to aciclovir is an increasing problem in such patients, in particular those infected with HIV, and may necessitate treatment with intravenous foscarnet.Keywords
This publication has 40 references indexed in Scilit:
- AciclovirDrugs, 1994
- Successful Treatment with Foscarnet of an Acyclovir-Resistant Mucocutaneous Infection with Herpes Simplex Virus in a Patient with Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1989
- Acyclovir-Resistant Herpes Simplex Virus Infections in Patients with the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1989
- Oral acyclovir for episodic treatment of recurrent genital herpesJournal of the American Academy of Dermatology, 1986
- A Double-Blind Study of Oral Acyclovir for Suppression of Recurrences of Genital Herpes Simplex Virus InfectionNew England Journal of Medicine, 1984
- Suppression of Frequently Recurring Genital HerpesNew England Journal of Medicine, 1984
- Treatment of First Episodes of Genital Herpes Simplex Virus Infection with Oral AcyclovirNew England Journal of Medicine, 1983
- A Trial of Topical Acyclovir in Genital Herpes Simplex Virus InfectionsNew England Journal of Medicine, 1982
- Severe Acquired Immunodeficiency in Male Homosexuals, Manifested by Chronic Perianal Ulcerative Herpes Simplex LesionsNew England Journal of Medicine, 1981
- Risk of Recurrence after First Episodes of Genital HerpesNew England Journal of Medicine, 1981